Investing.com - Sonoma Pharma (NASDAQ: SNOA) reported second quarter EPS of $-0.189, in line with the analyst estimate of $-0.189. Revenue for the quarter came in at $3.6M versus the consensus estimate of $3.59M.
Sonoma Pharma's stock price closed at $0.160. It is down -81.620% in the last 3 months and down -92.780% in the last 12 months.
Sonoma Pharma saw positive EPS revisions and negative EPS revisions in the last 90 days. See Sonoma Pharma's stock price’s past reactions to earnings here.
According to InvestingPro, Sonoma Pharma's Financial Health score is "fair performance".
Check out Sonoma Pharma's recent earnings performance, and Sonoma Pharma's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar